DRY POWDER FORMULATION COMPRISING A PHOSPHODIESTERASE INHIBITOR
Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD. 本发明涉及包含磷酸二酯酶-4抑制剂颗粒作为活性成分的可吸入干粉形式的药物制剂。本发明还涉及其制备方法,并且涉及其在预防和/或...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
27.06.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Pharmaceutical formulations in the form of inhalable dry powder comprising particles of a phosphodiesterase-4 inhibitor as active ingredient are useful for the prevention and/or treatment of respiratory diseases, such as asthma and COPD.
本发明涉及包含磷酸二酯酶-4抑制剂颗粒作为活性成分的可吸入干粉形式的药物制剂。本发明还涉及其制备方法,并且涉及其在预防和/或治疗呼吸道疾病(如,哮喘和COPD)中的用途。 |
---|---|
Bibliography: | Application Number: CN201710259305 |